Ameliora Wealth Management Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Ameliora Wealth Management Ltd.

$240 Billion
Q3 2024

A detailed history of Ameliora Wealth Management Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameliora Wealth Management Ltd. holds 3,340 shares of REGN stock, worth $2.49 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

3,340

Previous 3,354 0.42%

Holding current value

$2.49 Million

Previous $3.53 Billion 0.4%

% of portfolio

1.46%

Previous 1.6%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$1024.09 - $1201.76 $14,337 - $16,824	-14 Reduced 0.42%	3,340 $3.51 Billion
Q2 2024 Jul 16, 2024	BUY	$883.2 - $1071.19 $84,787 - $102,834	96 Added 2.95%	3,354 $3.53 Billion
Q1 2024 Apr 16, 2024	SELL	$902.69 - $993.35 $5,416 - $5,960	-6 Reduced 0.18%	3,258 $3.14 Billion
Q4 2023 Jan 10, 2024	BUY	$775.18 - $881.7 $86,044 - $97,868	111 Added 3.52%	3,264 $2.87 Billion
Q3 2023 Oct 10, 2023	BUY	$692.45 - $844.37 $486,792 - $593,592	703 Added 28.69%	3,153 $2.59 Billion
Q2 2023 Jul 10, 2023	SELL	$700.03 - $830.35 $79,803 - $94,659	-114 Reduced 4.45%	2,450 $1.76 Billion
Q1 2023 Apr 17, 2023	SELL	$680.49 - $826.97 $791,409 - $961,766	-1,163 Reduced 31.2%	2,564 $2.11 Billion
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $1.21 Million - $1.31 Million	1,710 Added 84.78%	3,727 $2.69 Billion
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $1.12 Million - $1.42 Million	1,960 Added 3438.6%	2,017 $1.47 Million
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $2.05 Million - $2.76 Million	-3,739 Reduced 98.5%	57 $33,000
Q1 2022 Apr 26, 2022	BUY	$595.12 - $698.43 $2.26 Million - $2.65 Million	3,796 New	3,796 $2.44 Million

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameliora Wealth Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Ameliora Wealth Management Ltd. with notifications on news.

Account

Ameliora Wealth Management Ltd. Regeneron Pharmaceuticals, Inc. Transaction History